(Q56897594)

English

Combination therapy of immunocytokines with ipilimumab: a cure for melanoma?

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Combination therapy of immunocytokines with ipilimumab: a cure for melanoma? (English)

0 references

3

Meenhard Herlyn

0 references

Rajasekharan Somasundaram

series ordinal

2

object named as

Rajasekharan Somasundaram

0 references

author name string

Tao Wang

series ordinal

1

0 references

language of work or name

English

0 references

publication date

March 2013

0 references

published in

Journal of Investigative Dermatology

0 references

volume

133

0 references

issue

3

0 references

page(s)

595-596

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/jid.2012.433

0 references

cites work

Targeted cytokine delivery to neuroblastoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcellular-resolution delivery of a cytokine through precisely manipulated nanowires

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

New strategies in metastatic melanoma: oncogene-defined taxonomy leads to therapeutic advances

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer immunotherapy comes of age

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Small-animal PET of tumor angiogenesis using a (76)Br-labeled human recombinant antibody fragment to the ED-B domain of fibronectin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunocytokine L19-IL2 eradicates cancer when used in combination with CTLA-4 blockade or with L19-TNF.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The targeted immunocytokine L19-IL2 efficiently inhibits the growth of orthotopic pancreatic cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FJID.2012.433

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1038/JID.2012.433

0 references

PubMed publication ID

23399823

0 references

(Q56897594)

Combination therapy of immunocytokines with ipilimumab: a cure for melanoma?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)